Alexander F Markham Selected Research

Alexander F Markham Research Topics

Disease

11	Neoplasms (Cancer) 04/2021 - 10/2002
6	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2002
5	Carcinogenesis 04/2021 - 01/2002
4	Adenoma (Adenomas) 04/2021 - 10/2002
3	Primary Hypertrophic Osteoarthropathy (Hypertrophic Osteoarthropathy, Primary) 08/2012 - 06/2008
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 04/2021 - 11/2005
1	Melanoma (Melanoma, Malignant) 04/2021
1	Mesothelioma 11/2020
1	Cholangiocarcinoma 10/2020
1	Liposarcoma 12/2013
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 06/2013
1	Turcot syndrome 06/2013
1	Microsatellite Instability 06/2013
1	Primary Myelofibrosis (Myelosclerosis) 08/2012
1	Bone Fractures (Bone Fracture) 02/2011
1	Familial Exudative Vitreoretinopathies 12/2010
1	Papillon-Lefevre Disease 05/2006
1	Lymphopenia (Lymphocytopenia) 01/2005
1	Rheumatoid Arthritis 01/2005
1	Mitochondrial Diseases (Mitochondrial Disease) 03/2004
1	Parkinson Disease (Parkinson's Disease) 11/2003
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2003
1	Parkinsonian Disorders (Parkinsonism) 11/2003
1	Alzheimer Disease (Alzheimer's Disease) 11/2003
1	Breast Neoplasms (Breast Cancer) 10/2003
1	Inflammation (Inflammations) 10/2002
1	Polyps 10/2002
1	Stomach Neoplasms (Stomach Cancer) 10/2002
1	Microcephaly 07/2002
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 04/2002
1	Latent Infection 11/2000

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 12/2013 - 11/2000
4	DNA (Deoxyribonucleic Acid)IBA 11/2017 - 10/2003
2	CateninsIBA 04/2021 - 01/2017
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 01/2020
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2017 - 10/2002
2	15-hydroxyprostaglandin dehydrogenaseIBA 06/2010 - 06/2008
1	lysyllysine (Lys-Lys)IBA 04/2021
1	Calcibiotic Root Canal SealerIBA 04/2021
1	mouse lysozyme MIBA 04/2021
1	enhanced green fluorescent proteinIBA 04/2021
1	GoldIBA 11/2020
1	Biomarkers (Surrogate Marker)IBA 10/2020
1	Liposomes (Liposome)IBA 01/2020
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2017
1	Muramidase (Lysozyme)IBA 01/2017
1	ProstaglandinsIBA 08/2012
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 02/2011
1	ChromatinIBA 01/2011
1	MethyltransferasesIBA 01/2011
1	Retinaldehyde (Retinal)IBA 12/2010
1	Prostaglandins EIBA 06/2010
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2010
1	Cathepsin CIBA 05/2006
1	Granzymes (Granzyme)IBA 05/2006
1	Macrophage Migration-Inhibitory FactorsIBA 11/2005
1	Messenger RNA (mRNA)IBA 11/2005
1	Interleukin-7 (Interleukin 7)IBA 01/2005
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 03/2004
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 11/2003
1	polyglutamineIBA 11/2003
1	Ligases (Synthetase)IBA 11/2003
1	TransferasesIBA 10/2003
1	Cyclooxygenase InhibitorsIBA 10/2002
1	Proto-Oncogene Proteins c-pim-1 (Proto Oncogene Proteins c pim 1)IBA 04/2002
1	TCF Transcription FactorsIBA 01/2002
1	gamma Catenin (Plakoglobin)IBA 01/2002
1	beta CateninIBA 01/2002
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2002

Therapy/Procedure

3	Microbubbles 11/2020 - 01/2020
3	Drug Therapy (Chemotherapy) 01/2020 - 01/2005
3	Chemoprevention 01/2017 - 10/2002
2	Therapeutics 04/2021 - 01/2005
1	Intravenous Injections 01/2020